Back to News & Events

Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support

Medisafe has raised $30 million in Series C funding with investments led by Sanofi Ventures and ALIVE Israel HealthTech Fund, joined by Leumi Partners, Menorah Mivtachim and Consensus Business Group, along with previous investors Pitango Ventures, 7Wire Ventures, Merck Ventures, Octopus Ventures, lool HealthTech, Triventures and Ourcrowd.

You may also like

How AI Can Help Make HCPs “More Human”

Emre Ozcan, PhD, SVP, Head of Global Digital Health, Merck KGaA Darmstadt Germany and Omri Shor, CEO and Founder, Medisafe 

..Read More
Webinars

Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in 

..Read More

Innovating Rare Disease Treatment: Integrating Digital Tools from Day One

In this webinar, UCB Pharma and the Les Turner ALS Foundation joined Medisafe discuss the integration of digital tools in 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us